We serve Chemical Name:3-Chloro-2-nitrotoluene CAS:5367-26-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Chloro-2-nitrotoluene
CAS.NO:5367-26-0
Synonyms:1-Chloro-3-methyl-2-nitrobenzene;2-Nitro-3-Chlorotoluene;Benzene, 1-chloro-3-methyl-2-nitro-
Molecular Formula:C7H6ClNO2
Molecular Weight:171.581
HS Code:2904909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:251.9±20.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.570
PSA:45.82000
Exact Mass:171.008713
LogP:2.80
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-Chloro-3-methyl-2-nitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene, 1-chloro-3-methyl-2-nitro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene, 1-chloro-3-methyl-2-nitro- Use and application,2-Nitro-3-Chlorotoluene technical grade,usp/ep/jp grade.
Related News: Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives. 3-Chloro-2-nitrotoluene manufacturer The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 3-Chloro-2-nitrotoluene supplier At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up. 3-Chloro-2-nitrotoluene vendor There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 3-Chloro-2-nitrotoluene factory The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement.
